2005

Cígler P., Kožíšek M., Řezáčová P., Brynda J., Otwinowski Z., Pokorná J., Plešek J., Gruner B., Dolečková-Marešová L., Máša M., Sedláček J., Bodem J., Krausslich H.-G., Král V., Konvalinka J.:
From nonpeptide toward noncarbon protease inhibitors: Metallacarboranes as specific and potent inhibitors of HIV protease.
Proceedings of the National Academy of Sciences of the United States of America 43 (102): 15394-15399, 2005.

Caffrey C.R., Plachá L., Bařinka C., Hradílek M., Dostál J., Sajid M., McKerrow J.H., Majer P., Konvalinka J., Vondrášek J.:
Homology modeling and SAR analysis of Schistosoma japonicum cathepsin D (SjCD) with statin inhibitors identify a unique active site steric barrier with potential for the design of specific inhibitors.
Biological Chemistry 4 (386): 339-349, 2005.

Stříšovský K., Jirásková J., Mikulová A., Rulíšek L., Konvalinka J.:
Dual substrate and reaction specificity in mouse serine racemase: Identification of high-affinity dicarboxylate substrate and inhibitors and analysis of the Î2-eliminase activity.
Biochemistry 39 (44): 13091-13100, 2005.

Václavíková J., Weber J., Machala L., Reinis M., Linka M., Brůčková M., Vandasová J., Staňková M., Konvalinka J.:
Long-term analysis of the resistance development in HIV-1 positive patients treated with protease and reverse transcriptase inhibitors: correlation of the genotype and disease progression..
Acta virologica. English ed 1 (49): 29-36, 2005.

Václavíková J., Machala L., Staňková M., Linka M., Brůčková M., Vandasová J., Konvalinka J.:
Response of HIV positive patients to the long-term salvage therapy by lopinavir/ritonavir.
Journal of Clinical Virology 4 (33): 319-323, 2005.